Scientist.com has announced the completion of a four-part podcast series on human biological samples and biobanking. The four guests offered thoughtful insights and ideas from an academic, pharmaceutical and small business perspective. The episodes were hosted by, and are currently available on Mendelspod, one of the life science industry’s leading podcasts.
Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo, among others.
The series featured experts in biospecimen regulation, biobanking and compliance, including Carolyn Compton, PhD, Chief Medical Officer of the National Biomarker Development Alliance and ASU professor; Shannon McCall, PhD, Director of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University; Kirstin Goldring, PhD, Counselor at the European Society for Biopreservation and Biobanking and member of ISBER; and Matt McLoughlin, Vice President of Compliance at Scientist.com.
Topics covered ranged from the sustainability of biobanks to a discussion of COMPLi™—Scientist.com’s proprietary compliance framework for overseeing the acquisition of human biological samples for research.
Scientist.com is the world’s leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH).
“This is the second time we’ve covered human biospecimen quality and governance on this show, which tells me that people are interested and looking for answers,” … “What Scientist.com is doing—offering a self-regulatory solution within the life sciences—is a practical first step toward filling an important gap.” – Theral Timpson, Host, Producer and Co-Founder of Mendelspod
“It was an honor to be included amongst a group of such distinguished and knowledgeable speakers on the topic of human biospecimen quality and biobanking,” … “Forums like these raise awareness regarding the sustainability of biobanks and help us create a more standardized set of rules governing human biospecimen acquisition.” – Matt McLoughlin, Vice President of Compliance at Scientist.com
Sources:
- https://www.businesswire.com/news/home/20181008005095/en/Scientist.com-Announces-Fourth-Podcast-Mendelspod-Series-Human
- https://mendelspod.com/podcasts/market-solution-biospecimen-quality-standards-matt-mcloughlin-scientistcom/
About the Author
David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.
